Compare Equity Development Investment Tbk. (GSMF) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equity Development Investment Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Equity Development Investment Tbk. trades at Rp90 (market cap 1.33T, 17.1M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 9.5× Equity Development Investment Tbk.'s market cap, and Equity Development Investment Tbk. is more actively traded (17.1M versus 235.2K). Which is the better fit depends on your goals.
| GSMF | TSPC | |
|---|---|---|
Market Cap | 1.33T | 12.58T |
Volume | 17.1M | 235.2K |
Lot | 171.03K | 2.35K |
Turnover | 1.54B | 649.94M |
Average Price | 90.3 | 2,763.37 |
Value | 1.54B | 649.94M |
Indicative Equilibrium Price | 90 | 2,780 |
Indicative Equilibrium Volume | 5.11K | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equity Development Investment Tbk.
PT Equity Development Investment Tbk (the “Company”) was established in Jakarta under the name of PT Gajah Surya Arta Leasing on November 1, 1982 based on the Notarial Deed of Didi Sudjadi, S.H., No. 1, as amended by deed No. 30 dated March 6, 1985 of the same notary. The Company changed its name to be PT BDNI Capital Corporation Tbk. On February 7, 2001, it changed the named again to be PT GT Investama Kapital, Tbk.
Read more on GSMF →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
